Groowe Groowe BETA / Newsroom
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

Head and Neck Cancer Market to Expand at 7.8% CAGR During 2026-2030 as Immuno-Oncology Therapies Offer Promising Advances in HNC Treatments

globenewswire.com
PFE Pfizer Inc. is mentioned as a key industry player in the head and neck cancer market, indicating its involvement but without specific details on its performance or outlook in this segment. MRK Merck KGaA is listed as a key industry player in the head and neck cancer market. The article does not provide specific details about its performance or future prospects in this area. AZN AstraZeneca Plc is identified as a key industry player in the head and neck cancer market. The article does not offer specific sentiment or performance data related to AstraZeneca in this context. CHRS Coherus BioSciences is mentioned positively due to its acquisition of Surface Oncology Inc., which is expected to bolster its immuno-oncology portfolio and enhance its market position in head and neck cancer treatments.

Head and Neck Cancer Market to Expand at 7.8% CAGR During 2026-2030 as Immuno-Oncology Therapies Offer Promising Advances in HNC Treatments Dublin, April 02, 2026 (GLOBE NEWSWIRE) -- The "Head and Neck Cancer (HNC) Market Report 2026" has been added to ResearchAndMarkets.com's offering.

The global head and neck cancer (HNC) market is poised for significant growth, with projections indicating an increase from $2.16 billion in 2025 to $2.33 billion in 2026 at a CAGR of 7.8%. By 2030, the market is expected to reach $3.12 billion, fueled by investments in precision oncology, demand for minimally invasive treatments, and advancement in AI-assisted diagnostics.

Growth drivers include a rise in tobacco and alcohol consumption, an increase in HPV-related cancer cases, and a boost in oncology treatment infrastructure. Moreover, enhanced diagnostic technologies and heightened awareness of head and neck cancers are pivotal. The forecast period highlights a trend toward targeted treatments, immunotherapies, and advanced imaging techniques, alongside a shift to early cancer detection and multimodal treatment strategies.

Elevated smoking rates are a significant factor propelling market expansion. Smoking, influenced by stress, societal factors, and marketing, results in severe health risks. Head and neck cancer therapies address tobacco-induced molecular changes, aiming to counteract smoking-related carcinogens and enhance treatment outcomes. A 2024 European Respiratory Society study underscored this by revealing a stark rise in youth smoking rates.

Pharmaceutical companies are increasingly focusing on advanced therapies like immuno-oncology drugs to improve survival rates and address clinical challenges in complex cancers. In November 2024, Dr. Reddy's Laboratories introduced Toripalimab, an immuno-oncology drug for nasopharyngeal carcinoma, reducing disease progression risk significantly when paired with standard chemotherapy.

Strategic acquisitions, like Coherus BioSciences' purchase of Surface Oncology Inc., aim to bolster immuno-oncology portfolios. Coherus' acquisition is set to enhance its market position, integrating promising drug candidates under development for head and neck cancer treatment.

Key industry players include Pfizer Inc., Siemens Healthcare Private Limited, GlaxoSmithKline PLC, Merck KGaA, and AstraZeneca Plc, among others. Geographically, North America leads in market size, while Asia-Pacific is anticipated to experience the fastest growth. Market regions span Asia-Pacific, Western and Eastern Europe, North and South America, and other global sectors.

Why Purchase This Report?

Markets Covered:

Companies Mentioned: Major stakeholders such as Pfizer Inc., Siemens Healthcare, F. Hoffmann-La Roche, among others, feature prominently with strategic insights into their market activities.

Geographies Analyzed: Extensive coverage includes regions across Asia-Pacific, Western and Eastern Europe, North America, and beyond.

With a time frame encompassing historical data and forecasts up to 2036, this report is meticulously structured to facilitate strategic decision-making grounded in comprehensive, high-quality market analysis.

Key Attributes

The companies featured in this Head and Neck Cancer (HNC) market report include:

For more information about this report visit https://www.researchandmarkets.com/r/b414kp

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Attachment